Lombard Odier Asset Management (Switzerland)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-542,183	Closed	-$4.12M	–	337
2022 Q1	$4.12M	Sell	542,183 -507,764	-48%	-$4.82M	0.32%	65
2021 Q4	$10.7M	Buy	1,049,947 +88,808	+9%	+$1.13M	0.68%	53
2021 Q3	$12.9M	Buy	961,139 +145,823	+18%	+$2.38M	0.8%	53
2021 Q2	$17.9M	Buy	815,316 +213,725	+36%	+$4.75M	0.91%	47
2021 Q1	$14.5M	Buy	+601,591	New	+$14M	0.96%	43

Other funds holding GTHX

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s GTHX Position: Q2 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2022, closing a stake of 542,183 shares — an estimated $4.12M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in GTHX in Q1 2021 and held it in 5 quarters. The position peaked at $17.9M in Q2 2021. 98 funds tracked by Wall St. Rank hold GTHX as of Q2 2022.

Lombard Odier Asset Management (Switzerland) reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 542,183 G1 Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $4.12M.
Lombard Odier Asset Management (Switzerland) first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Lombard Odier Asset Management (Switzerland)'s G1 Therapeutics, Inc. Common Stock position peaked at $17.9M in Q2 2021.
98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q2 2022, filed 15 Aug 2022.